Ambu AS (CHIX:AMBUBC) Other Current Liabilities: kr6 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:AMBUBC Ambu AS CHIX:AMBUBC
80 GF Score
Price kr66.90
GF Value kr129.20
Valuation Significantly Undervalued
View Full Analysis

What is Ambu AS Other Current Liabilities?

Ambu AS CHIX:AMBUBC 80 Other Current Liabilities is kr6 Mil as of Mar. 2026. GuruFocus rates CHIX:AMBUBC with a GF Score™ of 80/100 and a GF Value™ of kr129.20 (Significantly Undervalued).

Ambu AS's other current liabilities for the quarter that ended in Mar. 2026 was kr6 Mil.

Ambu AS's quarterly other current liabilities increased from Sep. 2025 (kr3 Mil) to Dec. 2025 (kr6 Mil) but then from Dec. 2025 (kr6 Mil) to Mar. 2026 (kr6 Mil).

Ambu AS's annual other current liabilities declined from Sep. 2023 (kr9 Mil) to Sep. 2024 (kr6 Mil) and declined from Sep. 2024 (kr6 Mil) to Sep. 2025 (kr3 Mil).

Ambu AS Other Current Liabilities Related Terms

Ambu AS Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Ambu AS's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambu AS Other Current Liabilities Chart

Ambu AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 152.00 4.00 9.00 6.00 3.00

Ambu AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.00 1.00 3.00 6.00 6.00
CHIX:AMBUBC
80GF Score
Ambu AS CHIX:AMBUBC
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambu AS Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of kr6 Mil mean?
Ambu AS (CHIX:AMBUBC) has a Other Current Liabilities of kr6 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Ambu AS.
Is Ambu AS's Other Current Liabilities too high?
Ambu AS's current Other Current Liabilities is kr6 Mil. Overall, Ambu AS has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ambu AS's Other Current Liabilities compare to ABT and SYK?
Ambu AS's Other Current Liabilities of kr6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Ambu AS. Ambu AS's current Other Current Liabilities is kr6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambu AS stock overvalued right now?
Based on GuruFocus' analysis, Ambu AS (CHIX:AMBUBC) is currently considered Significantly Undervalued. The stock's GF Value™ is kr129.20, compared to a current price of kr66.90 — trading 48.2% below its estimated fair value. The current Other Current Liabilities is kr6 Mil. Ambu AS's overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Ambu AS (CHIX:AMBUBC), the current Other Current Liabilities is kr6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ambu AS (CHIX:AMBUBC) Overvalued in 2026?

Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued. The current stock price of kr66.90 is trading 48.2% below its estimated GF Value™ of kr129.20. GuruFocus considers Ambu AS to be Significantly Undervalued.

Key valuation signals for CHIX:AMBUBC:

  • Other Current Liabilities: kr6 Mil
  • GF Value™: kr129.20 vs. price of kr66.90 (48.2% below fair value)
  • GF Score™: 80/100

No single metric tells the full story. See the CHIX:AMBUBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ambu AS Business Description

Address Baltorpbakken 13, Ballerup, DNK, DK-2750
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
80GF Score

Get the complete analysis for CHIX:AMBUBC

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr66.90
Price
kr129.20
GF Value